Published in J Am Coll Radiol on November 01, 2010
Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol (2014) 0.81
Polymer film-nanoparticle composites as new multimodality, non-migrating breast biopsy markers. Eur Radiol (2015) 0.79
Guideline-inconsistent breast cancer screening for women over 50: a vignette-based survey. J Gen Intern Med (2013) 0.79
Evaluating surveillance breast imaging and biopsy in older breast cancer survivors. Int J Breast Cancer (2012) 0.79
Novel High Spatiotemporal Resolution Versus Standard-of-Care Dynamic Contrast-Enhanced Breast MRI: Comparison of Image Quality. Invest Radiol (2016) 0.78
Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks. Acad Radiol (2016) 0.75
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med (2007) 10.28
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med (2004) 8.91
Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet (2005) 6.18
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA (2004) 5.85
Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology (2004) 5.37
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol (2005) 4.35
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol (2008) 3.06
The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology (2007) 2.99
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78
Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol (2008) 2.52
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer (2005) 2.25
Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology (2007) 2.22
Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology (1999) 2.11
Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg (2008) 2.01
Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology (1995) 1.84
MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol (2003) 1.84
Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol (2004) 1.83
Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer (2003) 1.70
Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol (2000) 1.65
MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol (2003) 1.62
MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol (2003) 1.50
MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol (2005) 1.46
Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw (2009) 1.40
MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology (2003) 1.27
Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol (1997) 1.27
Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology (1999) 1.27
Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol (2004) 1.16
The ACR's Mammography Accreditation Program: ten years of experience since MQSA. J Am Coll Radiol (2005) 1.10
Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer (2000) 1.07
Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol (2005) 1.04
Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology (2007) 1.04
Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol (2002) 1.02
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02
Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol (2005) 1.01
MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol (2000) 1.00
Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol (2002) 0.98
MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol (2007) 0.96
The role of MRI in breast cancer screening. J Natl Compr Canc Netw (2009) 0.95
Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J (2002) 0.90
Role of magnetic resonance imaging and magnetic resonance imaging--guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol (1999) 0.88
MR imaging of the contralateral breast in patients after breast-conserving therapy. Eur Radiol (2003) 0.86
MR imaging of the breast: technical approach and clinical experience. Radiographics (1993) 0.86
Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg (1999) 0.84
The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer. Arch Surg (2004) 0.84
MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr (1997) 0.84
Breast MRI in the Evaluation of Patients with Occult Primary Breast Carcinoma. Breast J (1999) 0.77
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med (2004) 6.42
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain. Arch Intern Med (2009) 4.96
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Screening for breast cancer. JAMA (2005) 4.56
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28
Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med (2006) 3.95
Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology (2003) 3.90
Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst (2004) 3.86
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst (2010) 3.53
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell (2007) 3.44
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology (2012) 3.36
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Association between mammography timing and measures of screening performance in the United States. Radiology (2005) 2.85
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology (2009) 2.78
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med (2003) 2.72
Physician predictors of mammographic accuracy. J Natl Cancer Inst (2005) 2.72
Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat (2005) 2.53
CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov (2012) 2.51
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography. Radiology (2002) 2.36
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
Breast density legislation and opportunities for patient-centered outcomes research. Radiology (2012) 2.20
Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.18
Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA (2004) 2.07
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control (2014) 2.05
Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst (2010) 2.04
Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nat Biotechnol (2003) 2.03
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Testing the effect of computer-assisted detection on interpretive performance in screening mammography. AJR Am J Roentgenol (2006) 1.98
Mammographic breast density and family history of breast cancer. J Natl Cancer Inst (2003) 1.95
Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer (2006) 1.92
Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol (2009) 1.91
Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol (2007) 1.89
Trends in colonoscopy for colorectal cancer screening. Med Care (2007) 1.89
Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry. J Am Chem Soc (2002) 1.85
Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat Methods (2008) 1.84
Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev (2004) 1.82
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst (2013) 1.81
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst (2012) 1.80
Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.78
Novel use of single X-ray absorptiometry for measuring breast density. Technol Cancer Res Treat (2005) 1.78
Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect (2009) 1.77
Association between obesity and depression in middle-aged women. Gen Hosp Psychiatry (2007) 1.77
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology (2005) 1.75
Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev (2009) 1.75
Ets motifs are necessary for endothelial cell-specific expression of a 723-bp Tie-2 promoter/enhancer in Hprt targeted transgenic mice. Arterioscler Thromb Vasc Biol (2003) 1.72
Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst (2002) 1.70
Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Med Care (2006) 1.70
Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS). BMC Womens Health (2013) 1.61